プロバイオティクスの世界市場2025

Market Research Futureが発行した調査報告書(MRF9DC033)
◆英語タイトル:Global Probiotics Market Research Report Forecast to 2025
◆商品コード:MRF9DC033
◆発行会社(リサーチ会社):Market Research Future
◆発行日:2019年10月
◆ページ数:157
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:食品
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥485,050見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥681,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Research Future社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Research Future社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、プロバイオティクスの治療の世界市場について調査・分析し、エグゼクティブサマリー、市場紹介、調査方法、市場洞察、市場動向、市場要因分析、タイプ別(ビフィドバクテリウム、ラクトバチルス、その他)分析、用途別(機能性食品および飲料、ダイエットサプリメント、家畜栄養、その他)分析、地域別分析、競合分析、会社概要などを含め、以下の構成でお届けします。
・エグゼクティブサマリー
・市場紹介
・調査方法
・市場洞察
・市場動向
・市場要因分析
・プロバイオティクスの治療の世界市場:タイプ別(ビフィドバクテリウム、ラクトバチルス、その他)
・プロバイオティクスの治療の世界市場:用途別(機能性食品および飲料、ダイエットサプリメント、家畜栄養、その他)
・プロバイオティクスの治療の世界市場:地域別分析
・競合分析
・会社概要
【レポートの概要】

Probiotics Market Research Report – Global Forecast till 2025
Global Probiotics Market: Information by Type (Bifidobacterium, Lactobacillus and others), Application (Functional Food & Beverages, Dietary Supplements, Animal Nutrition and others) and Region (North America, Europe, Asia-Pacific, South America and Middle East & Africa) – Forecast till 2025

Market Analysis
Global Probiotics Market is expected to register a CAGR of 8.48% to attain USD 3,257.0 Million by the year 2025. Probiotics are live microbials that are used to keep and restoring gut microflora. These probiotics have found its application in various processed food and preventive healthcare products for humans as well as animals or livestock. Main forms of probiotic bacteria species used in application industries include those of the Bifidobacterium and Lactobacillus genus.. Rising consumer awareness about the benefits of probiotics and preventive healthcare has boosted the demand for probiotics, thereby boosting market growth. The functional food & beverages segment is predictable to be largest, registering a significant CAGR to attain the USD 1,749.6 million by the end of the year 2025. High intake of beverages, especially functional beverages, and dairy-based products is the primary determinant driving the growth of the segment. Even Though, the dietary supplements segment is projected being the fastest-growing during the forecast period. The global probiotics market is expected to register a significant increase over the forecast period. Hectic everyday schedules, long hours, and sedentary lifestyles have impacted eating habits as well as food choices, resulting in an increased prevalence of various lifestyle-related conditions such as diabetes and obesity. This has caused to increased demand for probiotic food & beverages. Moreover, surging demand for probiotics in developed and developing countries is propelling manufacturers of probiotics and probiotic products to emphasis on innovation. In This Way, product innovation and research and development have led to new development opportunities for probiotic manufacturers. The use of probiotics has gained popularity in recent years with the growing demand in various industries. Emphasis on the enhancing digestive health in humans and animals along with surging demand for natural functional ingredients in application industries are key driving factors for the global probiotics market growth. The North American probiotics market is probably greatest during the forecast period. The regional market represented 31.60% of the total market share in the year 2018. The US was the key contributor to the growth of the market. Propensity toward the human consumption of healthy and functional food & beverages is increasing in the country, leads to increased application of probiotics in the food industry. The Asia-Pacific market also holds a prominent share of the global probiotics market and is forecast to exhibit the main CAGR during the forecast period. Growth of the application industries in the region is driving the growth of the probiotics market. In Europe, Germany, France, and the UK are the key countries contributing significantly to market growth.

Market Segmentation
Based on type the Global Probiotics Market has been segmented into Bifidobacterium, Lactobacillus and Others. Based on Application the Global Probiotics Market has been segmented into Functional Food & Beverages, Dietary Supplements, Animal Nutrition and Others. Global Probiotics Market based on region is divided into different regions like North America (covering US, Canada and Mexico), Europe (covering Germany, UK, France, Spain, Italy, Russia and Rest of Europe), Asia-Pacific (covering China, Japan, India, Australia, Vietnam, South Korea and Rest of Asia-Pacific), South America (covering Brazil, Argentina, Colombia, Chile and Rest of South America) Middle East & Africa (covering Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of the Middle East & Africa).

Regional Analysis
Geographically, the Global Probiotics Market based on region is divided into different regions like North America (covering US, Canada and Mexico), Europe (covering Germany, UK, France, Spain, Italy, Russia and Rest of Europe), Asia-Pacific (covering China, Japan, India, Australia, Vietnam, South Korea and Rest of Asia-Pacific), South America (covering Brazil, Argentina, Colombia, Chile and Rest of South America) Middle East & Africa (covering Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of the Middle East & Africa).

Major Players
The proposed spectators in the Global Probiotics Market are hospitals, medical devices companies, Research and academic institutes, software companies Governments, associations, industrial bodies, etc. The major companies functioning in the Global Probiotics Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers are Probiotics manufacturers, Baby food manufacturers, Beverage industry, Dairy industry, Food processors, Animal feed manufacturers, Dietary supplements manufacturers, Traders, wholesalers, and distributors, Governments, associations, and industrial bodies, Investors and trade experts. Greentech SA (France), Biosearch, SA (Spain), and BioCC OÜ (Estonia), Lallemand Inc. (Canada), Probi AB (Sweden), CHR-Hansen A/S (Denmark), Novozymes A/S (Denmark), Roelmi HPC (Italy), UAS Laboratories LLC (US), Probiotical SpA (Italy), Kerry Group (Ireland), Sabinsa Corporation (US), DowDupont Inc. (US) Synbio Tech Inc. (Taiwan). Are some of the major players in the global probiotics market. The players that are active in the global probiotics market are focusing on product launches, mergers & acquisitions, joint ventures, and enhancing their global footprints by introducing the untapped markets.

【レポートの目次】

Table of Contents:

1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVENESS ANALYSIS
1.1.1 GLOBAL PROBIOTICS MARKET, BY TYPE
1.1.2 GLOBAL PREBIOTICS MARKET, BY APPLICATION
1.1.3 GLOBAL PROBIOTICS MARKET, BY REGION
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 KEY BUYING CRITERIA
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
3.6 LIST OF ASSUMPTIONS
4 MARKET INSIGHTS
5 MARKET DYNAMICS
5.1 INTRODUCTION
5.2 DRIVERS
5.2.1 INCREASING EMPHASIS ON IMPROVING DIGESTIVE HEALTH IN HUMANS AND ANIMALS
5.2.2 SURGING DEMAND FOR NATURAL FUNCTIONAL INGREDIENTS IN APPLICATION INDUSTRIES
5.2.3 DRIVERS IMPACT ANALYSIS
5.3 RESTRAINT
5.3.1 REGULATORY CONSTRAINTS
5.3.2 RESTRAINTS IMPACT ANALYSIS
5.4 OPPORTUNITIES
5.4.1 PRODUCT INNOVATION
6 MARKET FACTOR ANALYSIS
6.1 VALUE CHAIN ANALYSIS
6.1.1 RAW MATERIAL PROCUREMENT
6.1.2 PROCESSING
6.1.3 PACKAGING
6.2 SUPPLY CHAIN ANALYSIS
6.3 PORTER’S FIVE FORCES MODEL
6.3.1 THREAT OF NEW ENTRANTS
6.3.2 BARGAINING POWER OF SUPPLIERS
6.3.3 BARGAINING POWER OF BUYERS
6.3.4 THREAT OF SUBSTITUTES
6.3.5 INTENSITY OF RIVALRY
7 GLOBAL PROBIOTICS MARKET, BY TYPE
7.1 OVERVIEW
7.1.1 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY TYPE, 2014–2025
7.2 BIFIDOBACTERIUM
7.2.1 BIFIDOBACTERIUM: MARKET ESTIMATES & FORECAST, BY REGION, 2014–2025
7.3 LACTOBACILLUS
7.3.1 LACTOBACILLUS: MARKET ESTIMATES & FORECAST, BY REGION, 2014–2025
7.4 OTHERS
7.4.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2014–2025
8 GLOBAL PROBIOTICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.1.1 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY APPLICATION, 2014–2025
8.2 FUNCTIONAL FOOD & BEVERAGES
8.2.1 FUNCTIONAL FOOD & BEVERAGES: MARKET ESTIMATES & FORECAST, BY REGION, 2014–2025
8.3 DIETARY SUPPLEMENTS
8.3.1 DIETARY SUPPLEMENTS: MARKET ESTIMATES & FORECAST, BY REGION, 2014–2025
8.4 ANIMAL NUTRITION
8.4.1 ANIMAL NUTRITION: MARKET ESTIMATES & FORECAST, BY REGION, 2014–2025
8.5 OTHERS
8.5.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2014–2025
9 GLOBAL PROBIOTICS MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 SPAIN
9.3.5 ITALY
9.3.6 RUSSIA
9.3.7 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 VIETNAM
9.4.6 SOUTH KOREA
9.4.7 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 ARGENTINA
9.5.3 COLOMBIA
9.5.4 CHILE
9.5.5 REST OF SOUTH AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 SAUDI ARABIA
9.6.2 UAE
9.6.3 EGYPT
9.6.4 NIGERIA
9.6.5 SOUTH AFRICA
9.6.6 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 COMPETITIVE BENCHMARKING
10.3 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.3.1 PRODUCT LAUNCHES/SERVICE DEPLOYMENTS
10.3.2 MERGERS & ACQUISITIONS
10.3.3 JOINT VENTURES
10.3.4 EXPANSION
11 COMPANY PROFILES
11.1 CHR. HANSEN A/S
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 NOVOZYMES A/S
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 LALLEMAND INC.
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 PROBI AB
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 KERRY GROUP PLC
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 SABINSA CORPORATION
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 DOWDUPONT INC.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 SYNBIO TECH INC.
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 ROELMI HPC
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENT
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.1 UAS LABORATORIES LLC
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
11.11 PROBIOTICAL SPA
11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCTS OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 SWOT ANALYSIS
11.11.6 KEY STRATEGIES
11.12 GREENTECH SA
11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL OVERVIEW
11.12.3 PRODUCTS OFFERED
11.12.4 KEY DEVELOPMENTS
11.12.5 SWOT ANALYSIS
11.12.6 KEY STRATEGIES
11.13 BIOSEARCH, SA
11.13.1 COMPANY OVERVIEW
11.13.2 FINANCIAL OVERVIEW
11.13.3 PRODUCTS OFFERED
11.13.4 KEY DEVELOPMENTS
11.13.5 SWOT ANALYSIS
11.13.6 KEY STRATEGIES
11.14 BIOCC OÜ
11.14.1 COMPANY OVERVIEW
11.14.2 FINANCIAL OVERVIEW
11.14.3 PRODUCTS OFFERED
11.14.4 KEY DEVELOPMENTS
11.14.5 BIOCC OÜ PATENTS: PROBITOTICS MARKET
11.14.6 SWOT ANALYSIS
11.14.7 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES

List of Tables:

TABLE 1 PRIMARY INTERVIEWS
TABLE 2 LIST OF ASSUMPTIONS
TABLE 3 GLOBAL PROBIOTICS MARKET ESTIMATES, BY TYPE, 2014–2017 (USD MILLION)
TABLE 4 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY TYPE, 2018–2025 (USD MILLION)
TABLE 5 BIFIDOBACTERIUM: MARKET ESTIMATES, BY REGION, 2014–2017 (USD MILLION)
TABLE 6 BIFIDOBACTERIUM: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 LACTOBACILLUS: MARKET ESTIMATES, BY REGION, 2014–2017 (USD MILLION)
TABLE 8 LACTOBACILLUS: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 OTHERS: MARKET ESTIMATES, BY REGION, 2014–2017 (USD MILLION)
TABLE 10 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 GLOBAL PROBIOTICS MARKET ESTIMATES, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 12 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 13 FUNCTIONAL FOOD & BEVERAGES: MARKET ESTIMATES, BY REGION, 2014–2017 (USD MILLION)
TABLE 14 FUNCTIONAL FOOD & BEVERAGES: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 DIETARY SUPPLEMENTS: MARKET ESTIMATES, BY REGION, 2014–2017 (USD MILLION)
TABLE 16 DIETARY SUPPLEMENTS: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 ANIMAL NUTRITION: MARKET ESTIMATES, BY REGION, 2014–2017 (USD MILLION)
TABLE 18 ANIMAL NUTRITION: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 OTHERS: MARKET ESTIMATES, BY REGION, 2014–2017 (USD MILLION)
TABLE 20 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 GLOBAL: PROBIOTICS MARKET ESTIMATES & FORECAST, BY REGION, 2014–2025 (USD MILLION)
TABLE 22 GLOBAL PROBIOTICS MARKET ESTIMATES, BY REGION, 2014–2017 (USD MILLION)
TABLE 23 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: MARKET ESTIMATES, BY COUNTRY, 2014–2017 (USD MILLION)
TABLE 25 NORTH AMERICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 27 NORTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 28 NORTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 29 NORTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 30 US: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 31 US: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 32 US: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 33 US: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 34 CANADA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 35 CANADA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 CANADA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 37 CANADA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 38 MEXICO: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 39 MEXICO: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 MEXICO: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 41 MEXICO: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 42 EUROPE: MARKET ESTIMATES, BY COUNTRY, 2014–2017 (USD MILLION)
TABLE 43 EUROPE: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 45 EUROPE: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 EUROPE: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 47 EUROPE: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 48 GERMANY: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 49 GERMANY: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 GERMANY: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 51 GERMANY: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 52 UK: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 53 UK: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 UK: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 55 UK: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 56 FRANCE: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 57 FRANCE: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 58 FRANCE: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 59 FRANCE: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 60 SPAIN: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 61 SPAIN: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 62 SPAIN: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 63 SPAIN: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 64 ITALY: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 65 ITALY: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 ITALY: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 67 ITALY: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 68 RUSSIA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 69 RUSSIA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 RUSSIA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 71 RUSSIA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 72 REST OF EUROPE: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 73 REST OF EUROPE: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 REST OF EUROPE: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 75 REST OF EUROPE: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 76 ASIA-PACIFIC: MARKET ESTIMATES, BY COUNTRY, 2014–2017 (USD MILLION)
TABLE 77 ASIA-PACIFIC: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 ASIA-PACIFIC: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 79 ASIA-PACIFIC: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 ASIA-PACIFIC: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 81 ASIA-PACIFIC: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 82 CHINA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 83 CHINA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 CHINA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 85 CHINA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 86 JAPAN: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 87 JAPAN: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 JAPAN: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 89 JAPAN: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 90 INDIA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 91 INDIA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 INDIA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 93 INDIA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 94 AUSTRALIA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 95 AUSTRALIA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 AUSTRALIA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 97 AUSTRALIA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 98 VIETNAM: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 99 VIETNAM: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 VIETNAM: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 101 VIETNAM: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 102 SOUTH KOREA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 103 SOUTH KOREA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 SOUTH KOREA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 105 SOUTH KOREA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 106 REST OF ASIA-PACIFIC: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 107 REST OF ASIA-PACIFIC: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 REST OF ASIA-PACIFIC: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 109 REST OF ASIA-PACIFIC: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 110 SOUTH AMERICA: MARKET ESTIMATES, BY COUNTRY, 2014–2017 (USD MILLION)
TABLE 111 SOUTH AMERICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 112 SOUTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 113 SOUTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 SOUTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 115 SOUTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 116 BRAZIL: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 117 BRAZIL: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 BRAZIL: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 119 BRAZIL: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 120 ARGENTINA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 121 ARGENTINA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 ARGENTINA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 123 ARGENTINA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 124 COLOMBIA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 125 COLOMBIA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 COLOMBIA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 127 COLOMBIA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 128 CHILE: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 129 CHILE: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 CHILE: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 131 CHILE: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 132 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 133 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 135 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: MARKET ESTIMATES, BY COUNTRY, 2014–2017 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 138 MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 141 MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 142 SAUDI ARABIA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 143 SAUDI ARABIA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 SAUDI ARABIA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 145 SAUDI ARABIA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 146 UAE: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 147 UAE: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 UAE: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 149 UAE: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 150 EGYPT: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 151 EGYPT: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 EGYPT: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 153 EGYPT: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 154 NIGERIA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 155 NIGERIA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 156 NIGERIA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 157 NIGERIA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 158 SOUTH AFRICA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 159 SOUTH AFRICA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 SOUTH AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 161 SOUTH AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 162 REST OF MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY TYPE, 2014–2017 (USD MILLION)
TABLE 163 REST OF MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 REST OF MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2014–2017 (USD MILLION)
TABLE 165 REST OF MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 166 PRODUCT LAUNCHES/SERVICE DEPLOYMENTS
TABLE 167 MERGERS & ACQUISITIONS
TABLE 168 JOINT VENTURES
TABLE 169 EXPANSION
TABLE 170 CHR. HANSEN A/S: PRODUCTS OFFERED
TABLE 171 CHR. HANSEN A/S: KEY DEVELOPMENTS
TABLE 172 NOVOZYMES A/S: PRODUCTS OFFERED
TABLE 173 NOVOZYMES A/S: KEY DEVELOPMENTS
TABLE 174 LALLEMAND INC.: PRODUCTS OFFERED
TABLE 175 PROBI AB: PRODUCTS OFFERED
TABLE 176 PROBI AB: KEY DEVELOPMENTS
TABLE 177 KERRY GROUP PLC: PRODUCTS OFFERED
TABLE 178 KERRY GROUP PLC: KEY DEVELOPMENTS
TABLE 179 SABINSA CORPORATION: PRODUCTS OFFERED
TABLE 180 DOWDUPONT INC.: PRODUCTS OFFERED
TABLE 181 DOWDUPONT INC.: KEY DEVELOPMENTS
TABLE 182 SYNBIO TECH INC.: PRODUCTS OFFERED
TABLE 183 SYNBIO TECH INC.: KEY DEVELOPMENTS
TABLE 184 ROELMI HPC: PRODUCTS OFFERED
TABLE 185 UAS LABORATORIES LLC: PRODUCTS OFFERED
TABLE 186 UAS LABORATORIES LLC: KEY DEVELOPMENTS
TABLE 187 PROBIOTICAL SPA: PRODUCTS OFFERED
TABLE 188 THE COMPANY OFFERS PROBIOTIC PRODUCTS FOR NUTRACEUTICAL AND FUNCTIONAL FOOD APPLICATIONS. THE DETAILED INFORMATION IS NOT AVAILABLE ON THE COMPANY WEBSITE.
TABLE 189 BIOSEARCH, SA: PRODUCTS OFFERED
TABLE 190 BIOCC OÜ: PRODUCTS OFFERED

List of Figures:

FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL PROBIOTICS MARKET, 2018
FIGURE 3 GLOBAL PROBIOTICS MARKET ANALYSIS, BY TYPE
FIGURE 4 GLOBAL PREBIOTICS MARKET ANALYSIS, BY APPLICATION
FIGURE 5 GLOBAL PROBIOTICS MARKET ANALYSIS, BY REGION, 2018
FIGURE 6 GLOBAL PROBIOTICS MARKET: STRUCTURE
FIGURE 7 KEY BUYING CRITERIA FOR PREBIOTICS
FIGURE 8 RESEARCH PROCESS
FIGURE 9 TOP-DOWN & BOTTOM-UP APPROACHES
FIGURE 10 NORTH AMERICA: PROBIOTICS MARKET SIZE, BY COUNTRY (2018 VS 2025)
FIGURE 11 EUROPE: PROBIOTICS MARKET SIZE, BY COUNTRY (2018 VS 2025)
FIGURE 12 ASIA-PACIFIC: PROBIOTICS MARKET SIZE, BY COUNTRY (2018 VS 2025)
FIGURE 13 SOUTH AMERICA: PROBIOTICS MARKET SIZE, BY COUNTRY (2018 VS 2025)
FIGURE 14 MIDDLE EAST & AFRICA: PROBIOTICS MARKET SIZE, BY COUNTRY (2018 VS 2025)
FIGURE 15 MARKET DYNAMICS OVERVIEW
FIGURE 16 DRIVERS IMPACT ANALYSIS: GLOBAL PROBIOTICS MARKET
FIGURE 17 RESTRAINTS IMPACT ANALYSIS: GLOBAL PROBIOTICS MARKET
FIGURE 18 VALUE CHAIN: GLOBAL PROBIOTICS MARKET
FIGURE 19 GLOBAL PROBIOTICS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 21 GLOBAL PROBIOTICS MARKET, BY TYPE, 2018 (% SHARE)
FIGURE 22 GLOBAL PROBIOTICS MARKET, BY TYPE, 2017–2025 (USD MILLION)
FIGURE 23 GLOBAL PROBIOTICS MARKET SHARE, BY APPLICATION, 2018 (% SHARE)
FIGURE 24 GLOBAL PROBIOTICS MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
FIGURE 25 GLOBAL PROBIOTICS MARKET, BY REGION, 2017–2025 (USD MILLION)
FIGURE 26 GLOBAL PROBIOTICS MARKET, BY REGION, 2018 (% SHARE)
FIGURE 27 NORTH AMERICA: PROBIOTICS MARKET SHARE, BY COUNTRY, 2018 (% SHARE)
FIGURE 28 EUROPE: PROBIOTICS MARKET SHARE, BY COUNTRY, 2018 (% SHARE)
FIGURE 29 ASIA-PACIFIC: PROBIOTICS MARKET SHARE, BY COUNTRY, 2018 (% SHARE)
FIGURE 30 SOUTH AMERICA: PROBIOTICS MARKET SHARE, BY COUNTRY, 2018 (% SHARE)
FIGURE 31 MIDDLE EAST & AFRICA: PROBIOTICS MARKET SHARE, BY COUNTRY, 2018 (% SHARE)
FIGURE 32 CHR. HANSEN A/S: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 CHR. HANSEN A/S: SWOT ANALYSIS
FIGURE 34 NOVOZYMES A/S: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 NOVOZYMES A/S: SWOT ANALYSIS
FIGURE 36 LALLEMAND INC.: SWOT ANALYSIS
FIGURE 37 PROBI AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 PROBI AB: SWOT ANALYSIS
FIGURE 39 KERRY GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 KERRY GROUP PLC: SWOT ANALYSIS
FIGURE 41 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN.
FIGURE 42 SABINSA CORPORATION: SWOT ANALYSIS
FIGURE 43 DOWDUPONT INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 DOWDUPONT INC.: SWOT ANALYSIS
FIGURE 45 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN.
FIGURE 46 SYNBIO TECH INC.: SWOT ANALYSIS
FIGURE 47 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN.
FIGURE 48 THERE HAVE BEEN NO RECENT DEVELOPMENTS BY THE COMPANY IN THE GLOBAL PROBIOTICS MARKET.
FIGURE 49 ROELMI HPC: SWOT ANALYSIS
FIGURE 50 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN.
FIGURE 51 UAS LABORATORIES LLC: SWOT ANALYSIS
FIGURE 52 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN.
FIGURE 53 PROBIOTICAL SPA: SWOT ANALYSIS
FIGURE 54 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN.
FIGURE 55 GREENTECH SA: SWOT ANALYSIS
FIGURE 56 BIOSEARCH SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 57 BIOSEARCH, SA: SWOT ANALYSIS
FIGURE 58 BIOCC OÜ COMPANY: SWOT ANALYSIS

【掲載企業】

Greentech SA (France), Biosearch, SA (Spain), and BioCC OÜ (Estonia), Lallemand Inc. (Canada), Probi AB (Sweden), CHR-Hansen A/S (Denmark), Novozymes A/S (Denmark), Roelmi HPC (Italy), UAS Laboratories LLC (US), Probiotical SpA (Italy), Kerry Group (Ireland), Sabinsa Corporation (US), DowDupont Inc. (US) Synbio Tech Inc. (Taiwan)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ プロバイオティクスの世界市場2025(Global Probiotics Market Research Report Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆